DETAILS, FICTION AND SAFFRON TUBERCULOSIS TREATMENT

Pretomanid is currently being tested as part of a mix routine which includes moxifloxacin and PZA for the treatment of both of those drug-vulnerable and drug-resistant tuberculosis (ClinicalTrials.gov identifier: NCT02193776). Bedaquiline, approved because of the US FDA for treatment of multidrug-resistant tuberculosis in 2012, is additionally rema